Lawrence Erik Kurzius bought $936K of Elanco Animal Health Incorporated (ELAN)
Executed Aug 20, disclosed Aug 21, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Aug 21), the stock returned -6.2% (delay-adjusted); from the execution session (Aug 20), -7.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
Lawrence Erik Kurzius (Director) filed 11 Form 4 reports in the trailing twelve months (6 purchases, 5 sales), most often in McCormick & Company, Incorporated (MKC). Across 4 priced purchase filings, the average 21-session return was +3.7% from execution and +2.1% from disclosure (delay-adjusted; derived). The largest single filing was $10.8M of MKC (205,538 sh × $52.69, as filed), executed Aug 10.
Healthcare · Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm anim…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→10,000 sh × $21.30
Exec Dec 12 2025
Filed Dec 16 2025 · 4:42 PM ET ELANPURCHASE Elanco Animal Health Incorporated $211K
20,000 sh across 2 lots
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET